Recombinant Streptococcus pneumoniae ATP synthase subunit c (atpE) is a bioengineered protein derived from the bacterium Streptococcus pneumoniae. It represents the membrane-bound c-subunit of the F₀F₁ ATP synthase, an essential enzyme for converting proton gradients into ATP during oxidative phosphorylation. The recombinant form is typically expressed in heterologous systems (e.g., E. coli) with modifications such as N-terminal His-tags for purification and solubility enhancement .
Amino Acid Sequence: The full-length protein (1–66 residues) includes the conserved motif for proton translocation: MNLTFLGLCIACMGVSVGEGLLMNGLFKSVARQPDMLSEFRSLMFLGVAFIEGTFFVTLVFSFIIK .
UniProt IDs: Strain-specific variants include B2IQX6 (strain D39) and C1CLL2 (strain P1031) .
Tag: N-terminal His-tag (6xHis) for affinity chromatography .
Proton Conductance: As part of the F₀ sector, subunit c oligomerizes (c₁₀ ring) to form a proton channel, enabling proton translocation across the membrane .
ATP Synthesis: Coupled with subunit a and the F₁ sector, it drives ATP production via rotational catalysis .
Mutations in atpE (e.g., V48I, V60A) confer resistance to diarylquinoline antibiotics, which inhibit proton flow through subunit c. These mutations increase minimum inhibitory concentrations (MICs) by >100-fold in S. pneumoniae . Surface plasmon resonance (SPR) studies confirm direct binding of small-molecule inhibitors to purified subunit c .
Subunit c inhibitors reduce biofilm formation in S. pneumoniae and S. aureus, highlighting its role in microbial persistence .
The protein is explored as a vaccine antigen due to its conserved sequence across Streptococcus serotypes. Recombinant atpE is used in immunogenicity studies to induce protective immune responses .
Creative Biomart: Offers His-tagged recombinant atpE (Cat. No. RFL27869SF, RFL28915SF) .
Creative Biolabs: Provides strain-specific variants (e.g., Hungary19A-6) for vaccine research .
Cusabio: Supplies partial-length atpE for biochemical assays .
Point mutations (e.g., V48I, V60A) in atpE reduce inhibitor efficacy, necessitating combination therapies or next-generation drug designs .
Repeated freeze-thaw cycles degrade activity, requiring careful aliquoting and storage at -20°C/-80°C .
Subunit c sequences differ between Gram-positive (e.g., S. pneumoniae) and Gram-negative bacteria (e.g., E. coli), limiting broad-spectrum antibiotic applications .
KEGG: spr:spr1366
STRING: 171101.spr1366